
MYSURABLE
Innovative cloud-based solutions to measure the changes in the functional state of individuals related to the aging process.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
€50.0k | Support Program | ||
Total Funding | 000k |
EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 43 % | 182 % | 172 % | (13 %) | 254 % | (47 %) |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (410 %) | (252 %) | 269 % | 5 % | - | - | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (428 %) | (463 %) | 147 % | (48 %) | (84 %) | 15 % | 13 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Based in Bologna, Italy, Mysurable is a health-tech company established in 2018 as a spinoff of the University of Bologna. The firm was co-founded by Marco Domenicali, a geriatrician and professor; Enrico Lenzi, an electronic engineer specializing in system design; Antonio Domenicali, an engineer and entrepreneur; and Riccardo Piccioli, a seasoned manager with a background in marketing and sales at companies like Johnson & Johnson and Danone Group. This founding team combines deep experience in geriatric medicine, electronic engineering, and business management. Mysurable addresses the market of age-related health decline, providing technological solutions to measure changes in individuals' functional status.
The company's business model centers on providing integrated systems to healthcare professionals and facilities that serve the elderly population. Clients include doctors, physiotherapists, pharmacists, personal trainers, nursing homes, and other social care facilities. Mysurable develops and manages cloud-based solutions that integrate data from both traditional and proprietary devices, making the information consistently accessible to practitioners for personalizing diagnostic and therapeutic strategies. Revenue is generated through the sale of its product systems and related services. The company has received grant funding from investors including EIT Health, I3P, and Almacube.
Mysurable's core product is the mioTest® system, the first integrated platform for assessing muscle function and diagnosing sarcopenia—the excessive loss of muscle mass and strength due to aging. This system uses a combination of scientifically validated instruments, including a patented bio-impedance meter and a dynamic handgrip designed specifically for the elderly, to overcome measurement challenges like dehydration and tremors. The collected data on muscle performance, walking speed, and motor skills are processed by a cloud-based platform using a proprietary algorithm. This platform provides an immediate, integrated result and offers personalized recommendations on diet, physical activity, and lifestyle adjustments. The system is designed for broad use by non-medical personnel, facilitating large-scale screening programs. The company also offers the SPEED protocol (Sonographic Procedure for the Evaluation of Elderly with Disabilities) for assessing conditions in patients with severe disabilities to improve quality of life and reduce hospitalizations.
Keywords: geriatric health, functional status measurement, age-tech, sarcopenia diagnosis, muscle function assessment, cloud-based health platform, mioTest, remote patient monitoring, Bologna, University of Bologna spinoff, preventative healthcare, home diagnostics, elder care technology, disability management, bio-impedance meter, health screening, personalized medicine, medical devices, physiotherapy tools, healthcare data analytics